Dr. Luo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
365 Lennon Lane
Suite 250
Walnut Creek, CA 94598Phone+1 925-943-6800Fax+1 925-943-6880
Summary
- Caesar Luo, MD is an ophthalmologist based in Walnut Creek, CA with a subspecialty in retinal disease. He completed his fellowship in surgical retina and vitreous at Beaumont Hospital, Royal Oak, and his residency in ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye Hospital. He has experience dealing with conditions such as diabetes mellitus, diabetic retinopathy, vitreous detachment, retinal detachment, and posterior vitreous detachment. He has several publications in reputable journals, mainly specializing in retinal disease and diabetic vitrectomy. Dr. Luo currently serves as an ophthalmologist at Bay Area Retina Associates and has participated in critical clinical trials, such as the Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification.
Education & Training
- Beaumont Hospital, Royal OakFellowship, Surgical Retina and Vitreous, 2010 - 2012
- Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 2007 - 2010
- Albert Einstein Medical CenterInternship, Transitional Year, 2006 - 2007
- University of Rochester School of Medicine and DentistryClass of 2006
Certifications & Licensure
- CA State Medical License 2017 - 2026
- PA State Medical License 2006 - 2018
- NY State Medical License 2015 - 2017
- MI State Medical License 2010 - 2014
- DE State Medical License 2009 - 2011
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification Start of enrollment: 2018 Nov 15
Publications & Presentations
PubMed
- 1 citationsBETTER BASELINE VISION LEADS TO BETTER OUTCOMES AFTER THE 0.19-mg FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT IN DIABETIC MACULAR EDEMA.Victor H Gonzalez, Caesar Luo, David R P Almeida, Antonio Cutino, Brandon Coughlin
Retina. 2023-08-01 - Transvitreal and subretinal fibrinoid reaction following diabetic vitrectomy.Andrew J Nelson, Neesurg S Mehta, Jorge R Ochoa, Caesar Luo, Kareem Moussa
American Journal of Ophthalmology Case Reports. 2022-09-01 - 11 citationsAspirin use in central retinal arterial occlusion to prevent ischaemic stroke: a retrospective cohort study in Taiwan.Eugene Yu-Chuan Kang, Yun-Hsuan Lin, Nan-Kai Wang, Ling Yeung, Caesar Luo
BMJ Open. 2019-02-01
Press Mentions
- Leading Ophthalmologists to Discuss the Value of IRIDEX Solutions at AAOOctober 23rd, 2018
- Alimera Sciences Announces Nine Iluvien® Data Sets to Be Presented at 2017 American Academy of OphthalmologyOctober 28th, 2017
- Rediscovering Micropulse Laser TherapyAugust 30th, 2019
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: